Best of Cell Therapy

Technological breakthroughs and innovative strategies are propelling the ongoing evolution of CAR T cell therapy. 

Since the advent of T cell engineering in the 1990s, chimeric antigen receptor (CAR) T cell therapy has quickly emerged as a potent tool for killing cancer cells. Today, researchers are tackling the challenge of minimizing the side effects of CAR T cells while delving deeper into the dynamics of how these cells work and interact with tumors.

Download this Best of Drug Discovery News ebook to explore the history and science behind CAR T cell therapy and the innovative approaches scientists are using to engineer and optimize this groundbreaking treatment.

Supported by